Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activity of daptomycin against Listeria monocytogenes isolates from cerebrospinal fluid.

Literature DB >> 18285470

Activity of daptomycin against Listeria monocytogenes isolates from cerebrospinal fluid.

Lodewijk Spanjaard¹, Christina M J E Vandenbroucke-Grauls.

Abstract

We tested the activity of daptomycin against 76 Listeria monocytogenes isolates from cerebrospinal fluid by broth dilution and Etest methods. For the broth dilution method, the MIC range was 1.0 to 8.0 and the MIC at which 90% of the isolates tested were inhibited (MIC(90)) was 4.0 mg/liter. For the Etest method, the MIC range was 1.0 to 4.0 and the MIC(90) was 4.0 mg/liter. Presently, daptomycin cannot be recommended for the treatment of L. monocytogenes meningitis.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2008 PMID： 18285470 PMCID： PMC2346657 DOI： 10.1128/AAC.01139-07

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

14 in total

Review 1. Mechanisms of action of newer antibiotics for Gram-positive pathogens.

Authors: Robert Ew Hancock
Journal: Lancet Infect Dis Date: 2005-04 Impact factor: 25.071

2. Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method.

Authors: Yu-Tsung Huang; Chun-Hsing Liao; Lee-Jeng Teng; Po-Ren Hsueh
Journal: Antimicrob Agents Chemother Date: 2007-01-12 Impact factor: 5.191

3. In vitro activity of daptomycin against clinical isolates of Gram-positive bacteria.

Authors: Kerryl E Piper; James M Steckelberg; Robin Patel
Journal: J Infect Chemother Date: 2005-08 Impact factor: 2.211

4. The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates.

Authors: A King; I Phillips
Journal: J Antimicrob Chemother Date: 2001-08 Impact factor: 5.790

Review 5. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

Authors: Judith N Steenbergen; Jeff Alder; Grace M Thorne; Francis P Tally
Journal: J Antimicrob Chemother Date: 2005-02-10 Impact factor: 5.790

6. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.

Authors: Philippe Cottagnoud; Marc Pfister; Fernando Acosta; Marianne Cottagnoud; Lukas Flatz; Felix Kühn; Hans-Peter Müller; Armin Stucki
Journal: Antimicrob Agents Chemother Date: 2004-10 Impact factor: 5.191

3. Biocide-Tolerant Listeria monocytogenes Isolates from German Food Production Plants Do Not Show Cross-Resistance to Clinically Relevant Antibiotics.

Authors: A Roedel; R Dieckmann; H Brendebach; J A Hammerl; S Kleta; M Noll; S Al Dahouk; S Vincze
Journal: Appl Environ Microbiol Date: 2019-10-01 Impact factor: 4.792

3 in total

Activity of daptomycin against Listeria monocytogenes isolates from cerebrospinal fluid.

Review 1. Mechanisms of action of newer antibiotics for Gram-positive pathogens.

2. Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method.

3. In vitro activity of daptomycin against clinical isolates of Gram-positive bacteria.

4. The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates.

Review 5. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

6. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.

7. The incidence of bacterial meningitis in the Netherlands--a comparison of three registration systems, 1977-1982.

8. In vivo pharmacodynamic activity of daptomycin.

9. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects.

10. Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms.

Review 1. A current perspective on daptomycin for the clinical microbiologist.

2. Analysis of Genetic Diversity and Antibiotic Options for Clinical Listeria monocytogenes Infections in China.

3. Biocide-Tolerant Listeria monocytogenes Isolates from German Food Production Plants Do Not Show Cross-Resistance to Clinically Relevant Antibiotics.